메뉴 건너뛰기




Volumn 19, Issue 105, 2010, Pages 9-11

Nicotinic acid + laropiprant: Laropiprant adds its own adverse effects
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CREATINE KINASE; LAROPIPRANT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PRAVASTATIN; PROSTAGLANDIN D2; SIMVASTATIN; THROMBOXANE A2; ANTILIPEMIC AGENT; INDOLE DERIVATIVE; MK-0524;

EID: 76549103228     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (10)
  • 1
    • 76549129875 scopus 로고    scopus 로고
    • EMEA - CHMP European Public Assessment Report (EPAR) (révision 2) - Tredaptive. Scientific discussion H-C-889-IA-04 posted on EMEA website 27 January 2009: 57 pages.
    • EMEA - CHMP "European Public Assessment Report (EPAR) (révision 2) - Tredaptive. Scientific discussion H-C-889-IA-04" posted on EMEA website 27 January 2009: 57 pages.
  • 3
    • 76549105517 scopus 로고    scopus 로고
    • EMEA, Rapporteur's, Co-Rapporteur's 1 February, 83 pages
    • EMEA - Rapporteur's - Co-Rapporteur's "Day 150 joint response assessment report" 1 February 2008: 83 pages.
    • (2008) Day 150 joint response assessment report
  • 4
    • 76549102877 scopus 로고    scopus 로고
    • Merck & Co stops the ACHIEVE study
    • 3365-3366
    • "Merck & Co stops the ACHIEVE study" Scrip 2008; (3365-3366): 16-17.
    • (2008) Scrip , pp. 16-17
  • 5
    • 53149118030 scopus 로고    scopus 로고
    • Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia
    • Maccubbin D et al. "Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia" In J Clin Pract 2008; 62 (12): 1959-1970.
    • (2008) In J Clin Pract , vol.62 , Issue.12 , pp. 1959-1970
    • Maccubbin, D.1
  • 7
    • 43749087586 scopus 로고    scopus 로고
    • Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: Results from a randomised placebo-controlled clinical trial
    • Paolini JF et al. "Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: results from a randomised placebo-controlled clinical trial" Int J Clin Pract 2008; 62 (6): 896-904.
    • (2008) Int J Clin Pract , vol.62 , Issue.6 , pp. 896-904
    • Paolini, J.F.1
  • 9
    • 57349180892 scopus 로고    scopus 로고
    • Torcetrapib: Development abandoned
    • Prescrire Editorial Staff
    • Prescrire Editorial Staff "Torcetrapib: development abandoned" Prescrire Int 2007; 16 (89): 114.
    • (2007) Prescrire Int , vol.16 , Issue.89 , pp. 114
  • 10
    • 37849186974 scopus 로고    scopus 로고
    • Nicotinic acid
    • Prescrire Editorial Staff
    • Prescrire Editorial Staff "Nicotinic acid" Prescrire Int 2006; 15 (86): 213-216.
    • (2006) Prescrire Int , vol.15 , Issue.86 , pp. 213-216


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.